tapebrief

BG · Q2 2026 Earnings

Bullish

Bunge Global

Reported July 29, 2026

30-second summary

30-second take: Bunge posted Q2 FY2026 adjusted EPS of $2.00 (GAAP $3.47), beating consensus of $1.93 by 3.6% and revenue of $24.04B beating $22.35B consensus by 7.6% — Q2 came in above the ~$1.87 implied by last quarter's 40/60 H1/H2 split, unlocking a $0.25 raise at both ends of FY2026 adjusted EPS to $9.25–$9.75. Every non-EPS full-year metric was reaffirmed, including the $620–$660M net interest expense that stepped up last quarter, and $250M of Q2 buybacks confirms management is executing the remaining program rather than pulling forward. The bull case that Q1 wasn't a one-off is intact; the bear case is that the raise is $0.25, not $0.50, despite a Q2 beat of similar magnitude to Q1's — implying management is still husbanding H2 conservatism.

Headline numbers

EPS

Q2 FY2026

$2.00

+3.6% vs est.

Revenue

Q2 FY2026

$24.04B

+88.4% YoY

+7.6% vs est.

Gross margin

Q2 FY2026

7.0%

Operating margin

Q2 FY2026

4.4%

Key financials

Q2 FY2026
MetricQ2 FY2026Q2 FY2025YoYQ1 FY2026QoQ
Revenue$24.04B$12.77B+88.3%$21.86B+10.0%
EPS$2.00$1.31+52.7%$1.83+9.3%
Gross margin7.0%5.8%+120bps3.5%+349bps
Operating margin4.4%4.2%+19bps0.8%+357bps

Guidance

Bunge raised FY2026 adjusted EPS guidance by $0.25 at both ends of range (to $9.25–$9.75 from $9.00–$9.50), while reaffirming all other full-year guidance metrics; company delivered Q2 FY2026 earnings beat (+3.6% EPS surprise) and strong revenue beat (+7.6% surprise) driven by segment outperformance across Soybean Processing, Softseed Processing, and Grain Merchandising.

Guidance is issued for both next quarter and the full year. Both may appear below.

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Adjusted EPS
FY 2026
$9.00 to $9.50$9.25 to $9.75+$0.25 at both ends of rangeRaised

Reaffirmed unchanged this quarter: Net interest expense ($620 to $660 million), Adjusted annual effective tax rate (22% to 26%), Capital expenditures ($1.5 to $1.7 billion), Depreciation and amortization (approximately $975 million)

Segment performance

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Soybean Processing and Refining$12.071B+55.8%
Softseed Processing and Refining$4.095B+167.5%
Tropical Oils and Specialty Ingredients$1.259B+9.3%
Grain Merchandising and Milling$6.614B+183.1%

Platform metrics

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Soybeans Processed11,524 thousand metric tons
Soybeans Merchandised8,046 thousand metric tons
Softseeds Processed3,490 thousand metric tons
Softseeds Merchandised1,296 thousand metric tons

Profitability

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Adjusted Segment EBIT$796 million
Adjusted Total EBIT$665 million$293 million
Adjusted EPS Full-Year Guidance$9.25 to $9.75

Other KPIs

Q2 FY2026
SegmentQ2 FY2026
Share Repurchases$250 million

Management tone

No transcript was available for this quarter's brief; tone commentary is drawn from the press release language against the arc of prior quarters.

Narrative arc: Viterra dilutive, EPS cut → Synergies absorbed by financing drag → Synergies ahead of plan, guide raised → Q2 beat converts into a smaller, more measured raise

The Q1 message was one of inflection — "stronger, more agile, and better positioned than at any point in our history," synergies running ahead of plan with "significant network and commercial opportunities" beyond the cost program, and a $1.50 midpoint EPS raise that reframed Bunge as capable of $9+ combined-company earnings. This quarter, the press release language is markedly more restrained: "Our team delivered another strong quarter, navigating a complex global environment with agility, focus and disciplined execution," and "The drivers of long-term demand remain strong, and with our global footprint and enhanced capabilities, we are confident in our ability to execute across a wide range of market conditions." The two operative phrases — "complex global environment" and "wide range of market conditions" — are hedging language, not the inflection language of Q1. The company beat and raised, but the tone stepped back toward the Q4 FY2025 posture of managing expectations through visibility uncertainty.

The synergy narrative that carried Q1 is conspicuously absent from the Q2 press release. Q1's "network and commercial opportunities" beyond the cost program was the ceiling-lift signal; this quarter contains no equivalent update on synergy realization, incremental opportunity identification, or run-rate progression. Either synergies are executing quietly to plan (the benign read), or the "significant network and commercial opportunities" language did not survive scrutiny into Q2 (the bear read). Without the transcript, the ambiguity cannot be resolved this quarter — but the absence of a follow-through statement in a press release that could have easily included one is a soft signal that management is not pressing the incremental synergy story.

The buyback pace stayed disciplined rather than accelerating. Q2 saw $250M of repurchases, which matches the size of the remaining program that management said in Q1 would be completed by year-end. There is no evidence in the press release of pulling additional buyback forward into FY2026 — a signal that Moody's leverage constraints remain the binding factor and that the EPS raise has not yet freed up incremental cash return capacity.

The size of the raise is itself the tell. A $0.25 midpoint raise on a $0.13 Q2 beat lets management pass through the beat without leaning further on H2. That is the arithmetic of an organization that either genuinely doesn't have better visibility into H2 crush margins yet, or has visibility but is choosing to bank it as guide cushion. Given management's persistent H2 hedging language across four quarters, the second interpretation is at least as likely as the first.

Answers to last quarter's watch list

Q2 FY2026 adjusted EPS against the 40/60 split (needing >$1.70 to hold, >$2.00 to set up another raise) — Q2 came in at exactly $2.00, above the ~$1.87 implied midpoint and right at the threshold management flagged as guide-raise-inducing. The FY guide was raised $0.25 at both ends. H1 FY2026 adjusted EPS now totals $3.83 against the new $9.50 midpoint, implying H2 of ~$5.67 — meaning the 40/60 split has effectively re-cut to roughly 40/60 again on the new guide.
Resolved positively
Quantification of the "significant network and commercial opportunities" beyond cost synergies — Not addressed in the press release. Q1's language about synergy ceiling-lift did not carry forward, and no incremental synergy dollar figure or timeline was issued. Whether this is a quiet-execution posture or a soft retreat from the Q1 framing cannot be determined without the transcript.
Not resolved
Net interest expense run-rate within the $620–$660M range — Reaffirmed at $620–$660M for FY2026, with no change signaled and no refinancing update. The Q1 concern that the run-rate might push toward the high end is neither confirmed nor refuted this quarter.
Continue monitoring
Whether Tropical Oils & Specialty Ingredients and Grain Merchandising & Milling deteriorate further — Tropical Oils held roughly flat sequentially ($1.26B Q2 vs. $1.23B Q1) with YoY growth of +9.3%, slightly below Q1's +13.4% but not a step-down. Grain Merchandising revenue of $6.61B is below Q1's $7.18B — soft, but no further guidance revision was issued. Neither segment appears to be deteriorating in a way that threatens the FY raise, but neither is inflecting either.
Continue monitoring
Additional buyback pulled forward beyond the remaining $250M — No pull-forward disclosed. Q2 repurchases of $250M appear to close out the remaining program at the pace previously communicated, not above it. Status: Resolved negatively for the pull-forward thesis
RVO-driven H2 forward curve reversal — No management commentary on H2 curve shape in the press release. The FY guide raise implies the H2 setup has firmed marginally (the raise absorbs the Q2 beat without leaning on H2), but no explicit forward-curve read was provided.
Not resolved
Whether Q1 negative operating cash flow / working capital build normalized in Q2 — Not disclosed in the extracted numbers set; FCF is unavailable this quarter. Given the seasonal build pattern in agricultural processing, a Q2 recovery would be normal, but confirmation requires the cash flow statement detail.
Continue monitoring

What to watch into next quarter

Q3 FY2026 adjusted EPS against the implied H2 hockey stick — on the new $9.50 midpoint, H2 of ~$5.67 minus Q2's $2.00 implies H2 splits into Q3 + Q4 totaling $5.67; if management's prior H2 45/55 split still applies, that implies Q3 of ~$2.55 and Q4 of ~$3.12. A Q3 sub-$2.30 print would put the FY low end of $9.25 at risk

Whether management resurfaces the "network and commercial opportunities" synergy language on the Q3 call or Investor Day — the silence in the Q2 press release is either quiet execution or a soft retreat, and Q3 is the resolution point

Any refinancing signal on net interest expense — the FY $620–$660M range has now been reaffirmed for two consecutive quarters; a Q3 signal that 2027 could see a lower base would be a material tailwind that is not yet in any guide

Whether Grain Merchandising & Milling revenue and EBIT stabilize sequentially — Q2's $6.61B was below Q1's $7.18B; a third consecutive step-down would validate the "guided lower" framing from Q1 as a structural rather than a transitional issue

Whether the Q3 press release includes updated synergy realization figures against the $190M/$220M end-of-2026 markers set in Q4 FY2025 — the last hard synergy dollar disclosure was two quarters ago

Buyback pace in Q3 — with the remaining $250M program now consumed in Q2, any Q3 repurchase activity signals a new authorization or program extension, both of which would be first evidence of the EPS raise translating into incremental capital return

Sources

  1. Bunge Global Q2 FY2026 earnings press release (SEC EDGAR, filed July 29, 2026): https://www.sec.gov/Archives/edgar/data/1996862/000162828026050334/epr06302026.htm
  2. Tapebrief Q1 FY2026 brief for BG (internal reference for prior guidance baseline and watch list)
  3. Tapebrief Q4 FY2025 brief for BG (internal reference for narrative arc)
  4. Tapebrief Q3 FY2025 brief for BG (internal reference for narrative arc)
  5. Tapebrief Q2 FY2025 brief for BG (internal reference for narrative arc)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.